Daniel Grosslight
Stock Analyst at Citi
(3.57)
# 2,144
Out of 4,463 analysts
348
Total ratings
48.8%
Success rate
4.4%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMRS GMR Solutions | Initiated Coverage: Buy | $17 | $14.76 | +15.18% | 1 | Jun 8, 2026 | |
| ALGN Align Technology | Maintained: Buy | $240 | $181.49 | +32.24% | 2 | May 28, 2026 | |
| PHR Phreesia | Reiterated: Hold | $10 → $12 | $10.72 | +11.94% | 24 | May 28, 2026 | |
| ZTS Zoetis | Maintained: Buy | $145 → $112 | $72.45 | +54.59% | 2 | May 18, 2026 | |
| EVH Evolent Health | Maintained: Buy | $4 → $5.5 | $5.74 | -4.18% | 11 | May 15, 2026 | |
| AGL agilon health | Maintained: Hold | $19 → $80 | $111.74 | -28.41% | 9 | May 15, 2026 | |
| MCK McKesson | Rated: Buy | $860 → $945 | $768.06 | +23.04% | 15 | May 14, 2026 | |
| PAHC Phibro Animal Health | Rated: Hold | $62 → $44 | $32.10 | +37.07% | 2 | May 14, 2026 | |
| CTEV Claritev | Rated: Buy | $21 → $40 | $32.40 | +23.46% | 22 | May 14, 2026 | |
| GDRX GoodRx Holdings | Maintained: Buy | $3.5 → $4 | $3.06 | +30.72% | 28 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $26.88 | +19.05% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3.25 → $5 | $3.58 | +39.66% | 24 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $24 → $28 | $37.57 | -25.47% | 48 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $355 | $288.42 | +23.08% | 14 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $31 | $24.09 | +28.68% | 2 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 → $11 | $11.09 | -5.32% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $6 → $7 | $9.10 | -23.08% | 38 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $35 → $30 | $21.43 | +39.99% | 8 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $244 → $245 | $237.72 | +3.06% | 19 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $100 | $84.52 | +18.32% | 1 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $650 | $537.58 | +20.91% | 1 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $29 | $27.17 | +6.74% | 1 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.25 → $2.75 | $2.07 | +32.85% | 18 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $23.43 | n/a | 1 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.25 → $1.75 | $0.8866 | n/a | 10 | Sep 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $19 → $8 | $12.80 | n/a | 9 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $9 | $1.71 | n/a | 14 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $15 → $11 | $0.0001 | n/a | 6 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $5.20 | n/a | 8 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.15 → $0.45 | $0.000001 | n/a | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $10.60 | n/a | 1 | Dec 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $29.45 | n/a | 1 | Nov 19, 2019 |
GMR Solutions
Jun 8, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $14.76
Upside: +15.18%
Align Technology
May 28, 2026
Maintained: Buy
Price Target: $240
Current: $181.49
Upside: +32.24%
Phreesia
May 28, 2026
Reiterated: Hold
Price Target: $10 → $12
Current: $10.72
Upside: +11.94%
Zoetis
May 18, 2026
Maintained: Buy
Price Target: $145 → $112
Current: $72.45
Upside: +54.59%
Evolent Health
May 15, 2026
Maintained: Buy
Price Target: $4 → $5.5
Current: $5.74
Upside: -4.18%
agilon health
May 15, 2026
Maintained: Hold
Price Target: $19 → $80
Current: $111.74
Upside: -28.41%
McKesson
May 14, 2026
Rated: Buy
Price Target: $860 → $945
Current: $768.06
Upside: +23.04%
Phibro Animal Health
May 14, 2026
Rated: Hold
Price Target: $62 → $44
Current: $32.10
Upside: +37.07%
Claritev
May 14, 2026
Rated: Buy
Price Target: $21 → $40
Current: $32.40
Upside: +23.46%
GoodRx Holdings
May 14, 2026
Maintained: Buy
Price Target: $3.5 → $4
Current: $3.06
Upside: +30.72%
May 13, 2026
Maintained: Buy
Price Target: $32
Current: $26.88
Upside: +19.05%
May 12, 2026
Rated: Buy
Price Target: $3.25 → $5
Current: $3.58
Upside: +39.66%
May 12, 2026
Rated: Hold
Price Target: $24 → $28
Current: $37.57
Upside: -25.47%
May 7, 2026
Maintained: Buy
Price Target: $355
Current: $288.42
Upside: +23.08%
May 7, 2026
Maintained: Buy
Price Target: $30 → $31
Current: $24.09
Upside: +28.68%
May 6, 2026
Maintained: Sell
Price Target: $10 → $11
Current: $11.09
Upside: -5.32%
May 5, 2026
Rated: Hold
Price Target: $6 → $7
Current: $9.10
Upside: -23.08%
May 5, 2026
Rated: Buy
Price Target: $35 → $30
Current: $21.43
Upside: +39.99%
May 1, 2026
Rated: Buy
Price Target: $244 → $245
Current: $237.72
Upside: +3.06%
Apr 16, 2026
Initiated Coverage: Buy
Price Target: $100
Current: $84.52
Upside: +18.32%
Apr 16, 2026
Initiated Coverage: Hold
Price Target: $650
Current: $537.58
Upside: +20.91%
Apr 16, 2026
Initiated Coverage: Hold
Price Target: $29
Current: $27.17
Upside: +6.74%
Jan 9, 2026
Maintained: Hold
Price Target: $3.25 → $2.75
Current: $2.07
Upside: +32.85%
May 29, 2024
Maintained: Buy
Price Target: n/a
Current: $23.43
Upside: n/a
Sep 14, 2023
Maintained: Hold
Price Target: $1.25 → $1.75
Current: $0.8866
Upside: n/a
Aug 4, 2023
Downgraded: Sell
Price Target: $19 → $8
Current: $12.80
Upside: n/a
May 18, 2023
Maintained: Hold
Price Target: $7 → $9
Current: $1.71
Upside: n/a
Mar 9, 2023
Maintained: Hold
Price Target: $15 → $11
Current: $0.0001
Upside: n/a
Mar 1, 2023
Maintained: Hold
Price Target: $1
Current: $5.20
Upside: n/a
Nov 15, 2022
Maintained: Hold
Price Target: $1.15 → $0.45
Current: $0.000001
Upside: n/a
Dec 11, 2019
Initiated Coverage: Buy
Price Target: $13
Current: $10.60
Upside: n/a
Nov 19, 2019
Initiated Coverage: Buy
Price Target: $28
Current: $29.45
Upside: n/a